Homepage

After nearly a month orbiting the Earth attached to the International Space Station, the SpaceX Dragon capsule containing Dr. Abba Zubair's stem cell research detached ...

This story was previously published in Mayo Clinic Magazine. Steve Day is on a mission as he scans a crowd of about 150 people in the banquet hall of a golf course in his boyhood hometown of Sioux Falls, South Dakota. When he finally finds his target, he begins weaving through the crowd. Steve’s cane and wobbly amble are the only signs that something might be amiss with the retired grandfather. “Hi, Coach,” Steve says. “Steve Day? I can’t believe it’s you, and you’re here,” says David Kinney, Steve’s former wrestling coach who last talked to his Lincoln High pupil in 1969. Sometimes, Steve can’t believe he’s standing here either, in the aftermath of a diagnosis he formally received a little over three years ago at Mayo Clinic in Rochester, Minnesota. Steve’s balance issues, sleeping problems and irregular blood pressure stem from a rare, unusual neurodegenerative disease — multiple system atrophy.

Regenerative Medicine is an Established Priority at Mayo Clinic Five years is a short amount of time to expect results from a new strategic initiative at a complex organization. But early results were evident at the Mayo Clinic Symposium on Regenerative Medicine and Surgery. Mayo Clinic experts in regenerative medicine highlighted advancements in cancer care, cardiovascular disease, neurological conditions and musculoskeletal regeneration. More than 60 presenters from Mayo Clinic and Arizona State University shared results ranging from preliminary research to advanced discoveries in tissue engineering, cell-based therapies and cell-free therapies. The agenda included technical presentations that showed the expansive number of regenerative therapies being researched, translated and applied to patient care. The Symposium was moderated by the Center for Regenerative Medicine deputy director of education Richard Hayden, M.D.

On February 19, the latest rocket launch from NASA’s Kennedy Space Center in Cape Canaveral, Florida, included a payload of several samples of donated adult stem cells from a research laboratory at Mayo Clinic’s Florida campus. The launch by SpaceX, an American aerospace manufacturer and space transport services company, is part of NASA’s commercial resupply missions to the International Space Station. The biological cells come from the laboratory of Abba Zubair, M.D., Ph.D., who specializes in Transfusion Medicine and Regenerative Medicine. Dr. Zubair is leading regenerative medicine research to determine if healthy mesenchymal and hematopoietic stem cells, derived from the body’s bone marrow, can be mass-produced in the low-gravity environment of outer space. If the stem cells maintain their properties as they divide copiously in microgravity, they may be usable in the treatment of stroke.

Mayo Clinic’s Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) and Children’s Hospital of Philadelphia recently announced a collaboration to delay and prevent heart ...

Previously published on the Mayo Clinic News Network. Stem cell research is about to get a boost that’s out of this world. If all goes ...

When nerve cells in the brain and the spinal cord stop working normally there is a noticeable change in muscle movement and activity. Motor ...

It is not too late to register for the  Mayo Clinic Symposium on Regenerative Medicine and Surgery, Feb. 15-17, 2017 at the Westin Kierland Resort ...

Regenerative Medicine Minnesota recently announced the 2017 Regenerative Medicine Minnesota Research Awards. This year's research grants were aimed at developing and retaining early stage investigators. After review ...